Board-certified cardiologist, Leo Gozdecki, DO, is an expert in diagnosing and treating complex heart failure. With expertise in pulmonary hypertension, right ventricular failure and heart transplantation, Dr. Gozdecki provides comprehensive care that is tailored to each patient’s individual condition(s) and symptoms to enhance their quality of life. He also uses invasive hemodynamics, an advanced method of monitoring the heart for real-time information on how the heart is functioning, to manage heart failure for the best outcomes for his patients.
Using a patient-focused approach, Dr. Gozdecki builds long-term relationships with his patients that emphasizes open communication and trust in order to understand his patients' unique health challenges and develop personalized treatment plans. By focusing on patient dignity and individuality, his goal is to create a supportive and empathetic environment that encourages healing and well-being.
Beyond pulmonary hypertension: expanding the therapeutic frontier in chronic thromboembolic disease.
Beyond pulmonary hypertension: expanding the therapeutic frontier in chronic thromboembolic disease. J Thorac Dis. 2026 Sep 30; 18(9):1078.
PMID: 42865898
Sodium-Glucose Cotransporter 2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial.
Sodium-Glucose Cotransporter 2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial. JACC Heart Fail. 2026 Jun 30; 103225.
PMID: 42383961
Picking Up the Tempo on Treatment of Combined Post- and Pre-capillary Pulmonary Hypertension: Viewpoint on the CADENCE Trial.
Picking Up the Tempo on Treatment of Combined Post- and Pre-capillary Pulmonary Hypertension: Viewpoint on the CADENCE Trial. US Cardiol. 2026; 20:e11.
PMID: 42395899
Echocardiographic high-output heart failure is associated with worse survival among patients with myelofibrosis.
Echocardiographic high-output heart failure is associated with worse survival among patients with myelofibrosis. Cardiooncology. 2026 Mar 11; 12(1).
PMID: 41814386
Alternative Measures of Body Composition and Outcomes Following Heart Transplant.
Alternative Measures of Body Composition and Outcomes Following Heart Transplant. Clin Transplant. 2026 Feb; 40(2):e70448.
PMID: 41615227
Cross-pollination of two specialties: potential repurposing of cancer and cardiovascular drugs for the benefit of the other.
Cross-pollination of two specialties: potential repurposing of cancer and cardiovascular drugs for the benefit of the other. Future Cardiol. 2025 12; 21(12):1165-1175.
PMID: 41292504
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2025 Aug; 7(5):538-553.
PMID: 40668166
Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study.
Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study. J Card Fail. 2026 Jan; 32(1):46-57.
PMID: 39954845
Large Mass in the Left Atrium: The Usual Myxoma or Another Common Etiology?
Large Mass in the Left Atrium: The Usual Myxoma or Another Common Etiology? J Cardiothorac Vasc Anesth. 2022 12; 36(12):4541-4545.
PMID: 36123262
Protocol to improve hypertension management in a VA outpatient clinic.
Protocol to improve hypertension management in a VA outpatient clinic. J Hum Hypertens. 2023 01; 37(1):50-55.
PMID: 35067681